Recruiting Pancreatic Cancer Studies in Baltimore
The Cancer of the Pancreas Screening-5 CAPS5)Study
Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at thei...
Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC)
The purpose of this study is to determine the maximum tolerated dose of the chemotherapy drugs nab-paclitaxel and gemcitabine when combined with hypofractionated ablative proton therapy for the treatm...
About Pancreatic Cancer Clinical Trials in Baltimore
Pancreatic cancer begins in the tissues of the pancreas and is often diagnosed at an advanced stage. It is one of the most challenging cancers to treat. Clinical trials are actively investigating new approaches including immunotherapy and combination regimens.
There are currently 2 pancreatic cancer clinical trials recruiting participants in Baltimore, MARYLAND. These studies are seeking a combined 9,024 participants. Research is being sponsored by Johns Hopkins University, University of Maryland, Baltimore. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pancreatic Cancer Clinical Trials in Baltimore — FAQ
Are there pancreatic cancer clinical trials in Baltimore?
Yes, there are 2 pancreatic cancer clinical trials currently recruiting in Baltimore, MARYLAND. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Baltimore?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you about next steps.
Are clinical trials in Baltimore free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Baltimore studies also compensate for your time and travel.
What pancreatic cancer treatments are being tested?
The 2 active trials in Baltimore are testing new therapies including novel drugs, biologics, and treatment approaches for pancreatic cancer.
Data updated March 2, 2026 from ClinicalTrials.gov